RC
MDLN

Renaissance Capital’s Medline Inc MDLN Stock Holding History

Renaissance Capital’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.68M Buy
+150,304
New +$6.64M 4.84% 6

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Renaissance Capital's MDLN Position: Q1 2026 in Review

Renaissance Capital opened a new position in Medline Inc (MDLN) in Q1 2026: 150,304 shares worth $6.68M. The stake represents 4.84% of the portfolio and ranks #6 among its holdings.

314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Renaissance Capital held 150,304 shares of Medline Inc worth $6.68M as of Q1 2026.
  • Medline Inc was a new Renaissance Capital position in Q1 2026.
  • Medline Inc made up 4.84% of Renaissance Capital's portfolio in Q1 2026, its #6 holding.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Renaissance Capital's 13F filing for Q1 2026, filed 7 May 2026.